Precision cancer medicine: What has translated into clinical use in Belgium?

Delnord, M; Van Valckenborgh, Els; Hebrant, Aline; Antoniou, Aline; Van Hoof, Wannes; Waeytens, Anouk; Van den Bulcke, M

Delnord, M; Van Valckenborgh, Els; Hebrant, Aline; Antoniou, Aline; Van Hoof, Wannes; Waeytens, Anouk; Van den Bulcke, M.

Afiliação

Delnord M; Cancer Center, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium. Electronic address: Marie.delnord@sciensano.be.
Van Valckenborgh E; Cancer Center, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Hebrant A; Cancer Center, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Antoniou A; Quality of Laboratories, Sciensano, Brussels, Belgium.
Van Hoof W; Cancer Center, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Waeytens A; Health Care Department, National Institute for Health and Disability Insurance, Brussels, Belgium.
Van den Bulcke M; Cancer Center, Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Semin Cancer Biol ; 84: 255-262, 2022 09.

Article em En | MEDLINE | ID: mdl-34129914

Assuntos

Neoplasias; Medicina de Precisão; Bélgica; Sequenciamento de Nucleotídeos em Larga Escala; Humanos; Oncologia; Neoplasias/genética; Neoplasias/terapia

Palavras-chave

Genomics; Implementation assessment; Knowledge transfer; Knowledge translation; Next-generation sequencing; Precision oncology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicina de Precisão / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google